|
KMID : 0881720230380020069
|
|
Journal of Food Hygiene and Safety
2023 Volume.38 No. 2 p.69 ~ p.78
|
|
|
Protective Effect of Enzymatically Modified Stevia on C2C12 Cell-based Model of Dexamethasone-induced Muscle Atrophy
|
|
Oh Geon
Choi Sun-Il
Xionggao Han
Xiao Men
Lee Se-Jeong
Im Ji-Hyun
Lee Ho-Seong
Jung Hyeong-Dong
La Moon-Jin
Kwon Min-Hee
Lee Ok-Hwan
|
|
|
Abstract
|
|
|
|
This study aimed to investigate the protective effect of enzymatically modified stevia (EMS) on C2C12 cell-based model of dexamethasone (DEX)-induced muscle atrophy to provide baseline data for utilizing EMS in functional health products. C2C12 cells with DEX-induced muscle atrophy were treated with EMS (10, 50, and 100 μg/mL) for 24 h. C2C12 cells were treated with EMS and DEX to test their effects on cell viability and myotube formation (myotube diameter and fusion index), and analyze the expression of muscle strengthening or degrading protein markers. Schisandra chinensis Extract, a common functional ingredient, was used as a positive control. EMS did not show any cytotoxic effect at all treatment concentrations. Moreover, it exerted protective effects on C2C12 cell-based model of DEX-induced muscle atrophy at all concentrations. In addition, the positive effect of EMS on myotube formation was confirmed based on the measurement and comparison of the fusion index and myotube diameter when compared with myotubes treated with DEX alone. EMS treatment reduced the expression of muscle cell degradation-related proteins Fbx32 and MuRF1, and increased the expression of muscle strengthening and synthesis related proteins SIRT1 and p- Akt/Akt. Thus, EMS is a potential ingredient for developing functional health foods and should be further evaluated in preclinical models.
|
|
|
KEYWORD
|
|
|
Muscle atrophy, Sarcopenia, Enzymatically modified stevia, C2C12, Dexamethasone
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|